Recent advancements in single-cell RNA sequencing (scRNA-seq) have further illuminated the tumor immune microenvironment, revealing distinct populations of immune cells, including cytotoxic CD8+ T cells and regulatory T cells, which play critical roles in tumor progression and responses to therapy. The gene discussed is CD8A; the disease is neoplasm.